Risk factors and predictive indexes of early graft failure in liver transplantation

Italian Journal of Gastroenterology

Volumn 28, Issue 3, 1996, Pages 163-168

  Marino, I R ^a   Starzl, T E ^a   Aldrighetti, L ^a   Doria, C ^a   Morelli, F ^a   Gayowski, T J P ^b   Madariaga, J R ^a   Doyle, H R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Assessment of outcome model; Early graft failure; Liver transplantation; Predictors of transplantation failure

Indexed keywords

BILIRUBIN; CREATININE;

ADULT; AGE; ARTICLE; BILIRUBIN BLOOD LEVEL; CREATININE BLOOD LEVEL; DONOR; FEMALE; GRAFT FAILURE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PREOPERATIVE PERIOD; RISK FACTOR;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 0029974254     PISSN: 03920623     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Marino IR, Doyle HR, Fung JJ Liver. In; Higgins RSD, Sanchez JA, Lorber MI, Baldwin JC (Eds), The Multiorgan Donor. Blackwell Science, Inc., Publisher, Cambridge, MS. In press.
2. Starzl TE, Demetris AJ, Van Thiel DH. Medical progress: Liver transplantation. N Engl J Med 1989; 321(15): 1014-22.
3. Makowka L, Gordon RD, Todo S, et al. Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc 1987; 19(1): 2378-82.
4. Marino IR, Doyle HR, Aldrighetti L, et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995; 22(6): 1754-62.
5. Pruim J, Klompmaker IJ, Haagsma EB, Bijleveld CMA, Sloof MJH. Selection criteria for liver donation: a review. Transpl Int 1993; 6(4): 226-35.
6. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20(4): 829-38.
7. Rozga J, Podesta L, LePage E, et al. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 1993; 342(8876): 898-9.
8. Starzl TE, Fung JJ, Tzakis A, Todo S, Demetris AJ, Marino IR, et al. Baboon to human liver transplantation. Lancet 1993; 341(8837): 65-71.
9. Starzl TE, Valdivia L, Murase N, et al. The biologic basis of and strategies for clinical xenotransplantation. Immunol Rev 1994; 141: 213-44.
10. Takaya S, Iwaki Y, Starzl TE. Liver transplantation in positive cytotoxic crossmatch cases using FK506, highdose steroids, and prostaglandin E1. Transplantation 1992; 54(5): 927-9.
11. Starzl TE, Demetris AJ. Liver Transplantation. A 31-Year Perspective. Year Book Medical Publ, Inc., Chicago, 1990.
12. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101(6): 1644-55.
13. Gonzalez FX, Rimola A, Grande L, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994; 20(3): 565-73,
14. Starzl TE, Iwatsuki S, Van Thiel DH, et al. Evolution of liver transplantation. Hepatology 1982; 2(5): 614-36.
15. Doyle HR, Marino IR, Miro A, et al. Adult respiratory distress syndrome secondary to end-stage liver disease. Successful outcome following liver transplantation. Transplantation 1993; 55(2): 292-6.
16. Eghtesad B, Bronsther O, Irish W, et al. Disease gravity and urgency of need as guidelines for liver allocation. Hepatology 1994; 20(1 Pt. 2): 56S-62S.
17. Abu-Elmagd KM, Malinchoc M, Dickson ER, et al. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 1993; 177(4): 335-44.
18. Shaw BW, Wood RP, Gordon RD, Iwatsuki S, Gillquist WP, Starzl TE. Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis 1985; 5(4): 385-93.
19. Baliga P, Merion RM, Turcotte JG, et al. Preoperative risk factor assessment in liver transplantation. Surgery 1992; 112(4):704-11.
20. Cuervas-Mons V, Millan I, Gavaler JS, Starzl TE, Van Thiel DH. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology 1986; 6(5): 922-7.
21. Doyle HR, Marino IR, Morelli F, et al. Assessing risk in liver transplantation - With special reference to the significance of a positive cytotoxic crossmatch. Ann Surg. In press.
22. Starzl TE The Liver Donor. And, Appendix of Case Material and Bibliography. In: Starzl TE (Ed), (with the assistance C.W. Putnam). Experience in Hepatic Transplantation. WB Saunders Co., Philadelphia, 1969: 16-21 & 528-45.
23. Teperman L, Podesta L, Mieles L, Starzl TE. The successful use of older donors for liver transplantation. JAMA 1989; 262(20): 2837.
24. Wall WJ, Mimeault R, Grant DR, Bloch M. The use of older donor livers for hepatic transplantation. Transplantation 1990; 49(2): 377-81.
25. Marino IR, Doyle HR, Doria C, et al. Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc 1995; 27(1): 1184-5.
26. Doyle HR, Marino IR, Jabbour N, et al. Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted? Transplantation 1994; 57(7): 1028-36.